Publication Type:

Journal Article


Advanced Healthcare Materials, Volume 4, Number 5, p.679-684 (2015)



cancer therapy, Drug Resistance, Graphene, radiofrequency ablation, Transferrin


Under ultralow radiofrequency (RF) power, transferrin-conjugated graphene nanoparticles can thermally ablate drug- or radiation-resistant cancer cells very effectively. The results suggest that graphene-based RF hyperthermia can be an efficient method to manage drug-/radiation-resistant cancers.

Cite this Research Publication

A. Sasidharan, Sivaram, A. J., Retnakumari, A. P., Chandran, P., Malarvizhi, G. Loghanatha, Shantikumar V Nair, and Dr. Manzoor K., “Radiofrequency Ablation of Drug-Resistant Cancer Cells Using Molecularly Targeted Carboxyl-Functionalized Biodegradable Graphene”, Advanced Healthcare Materials, vol. 4, pp. 679-684, 2015.